Литература
1. Connolly., E. J., & Beaver., K. M. Examining the genetic and environmental influences on self-control and delinquency: Results from a genetically informative analysis of sibling pairs // Journal of Interpersonal Violence. 2004 Mar; 29 (4): 707–735.
2. Beaver., K. M., Eagle Schutt., J., Boutwell., B. B., Ratchford., M., Roberts., K., Barnes., J. C.Genetic and environmental influences on levels of self-control and delinquent peer affiliation: Results from a longitudinal sample of adolescent twins // Criminal Justice and Behavior 2008 Oct; 36 (1): 41–60.
3. Strauss., G. P., Frank., M. J., Waltz., J. A., Kasanova., Z., Herbener., E. S., Gold., J. M. Deficits in Positive Reinforcement Learning and Uncertainty-Driven Exploration are Associated with Distinct Aspects of Negative Symptoms in Schizophrenia // Biological Psychiatry 2011 Mar; 69 (5): 424–431.
4. Frank., M. J., Samanta., J., Moustafa., A. A., Sherman., S. J. Hold your horses: impulsivity., deep brain stimulation., and medication in parkinsonism // Science 2007 Nov; 318 (5854): 1309–1312.
5. Hegarty S. V., Sullivan A. M., O'Keeffe G. W. Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development // Developmental Biology. 2013 Jul 15; 379 (2): 123–38
6. Berridge K. C., Schulkin J. Palatability shift of a salt-associated incentive during sodium depletion. The Quarterly Journal of Experimental Psychology // 1989 May; 41 (2): 121–38.
7. Schultz W., Apicella P., Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task // Journal of Neuroscience. 1993 Mar; 13 (3): 900–13.
8. Knutson B., Fong G. W., Adams C. M., Varner J. L., Hommer D. Dissociation of reward anticipation and outcome with event-related fMRI // NeuroReport. 2001 Dec 4; 12 (17): 3683–7.
9. Berridge K. C., Robinson T. E. What is the role of dopamine in reward: hedonic impact., reward learning., or incentive salience? // Brain Research Reviews. 1998 Dec; 28 (3): 309–69.
10. Hopson J. Behavioral Game Design // Gamasutra.Com. The Art and Business of Making Games. 2001 Apr 27. URL: http://www.gamasutra.com/ view/feature/131494/behavioral_game_design.php.
11. Beaver K. M., Wright J. P., DeLisi M., Walsh A., Vaughn M. G., Boisvert D., Vaske J. A gene x gene interaction between DRD2 and DRD4 is associated with conduct disorder and antisocial behavior in males // Behavioral and Brain Functions. 2007 Jun 22; 3: 30.
12. El-Faddagh M., Laucht M., Maras A., Vöhringer L., Schmidt M. H. Association of dopamine D4receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: a longitudinal study from birth to 11 years of age // Journal of Neural Transmission (Vienna). 2004 Jul; 111 (7): 883–9.
13. Faraone S. V., Doyle A. E., Mick E., Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D (4) receptor gene and attention deficit hyperactivity disorder //American Journal of Psychiatry. 2001 Jul; 158 (7): 1052–7.
14. Duan J., Wainwright M. S., Comeron J. M., Saitou N., Sanders A. R., Gelernter J., Gejman P. V. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor // Human Molecular Genetics. 2003 Feb 1; 12 (3): 205–16.
15. Cerasa A., Gioia M. C., Tarantino P., Labate A., Arabia G., Annesi G., Lanza P., Di Palma G., Blasi V., Quattrone A. The DRD2 TaqIA polymorphism associated with changed midbrain volumes in healthy individuals // Genes., Brain and Behavior. 2009 Jun; 8 (4): 459–63.
16. Neville M. J., Johnstone E. C., Walton R. T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 // Human Mutation. 2004 Jun;23 (6): 540–5.
17. Pan Y. Q., Qiao L., Xue X. D., Fu J. H. Association between ANKK1 (rs1800497) polymorphism of DRD2 gene and attention deficit hyperactivity disorder: a meta-analysis // Neuroscience Letters. 2015Mar 17; 590: 101–5.
18. Käenmäki M., Tammimäki A., Myöhänen T., Pakarinen K., Amberg C., Karayiorgou M., Gogos J. A., Männistö P. T. Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice // Journal of neurochemistry. 2010 Sep;114 (6): 1745–55.
19. Pap D. et al. Genetic variants in the catechol-o-methyltransferase gene are associated with impulsivity and executive function: relevance for major depression // American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2012 Dec; 159B (8): 928–40.
20. Grace A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia // Neuroscience. 1991; 41 (1): 1–24.
21. Buckholtz J. W., Treadway M. T., Cowan R. L., Woodward N. D., Li R., Ansari M. S., Baldwin R. M., Schwartzman A. N., Shelby E. S., Smith C. E., Kessler R. M., Zald D. H. Dopaminergic network differences in human impulsivity // Science. 2010 Jul 30; 329 (5991): 532.
22. Шакиров М. Ш. Наркобизнес в России. – М.: Центрполиграф, 1998.
23. Гуртовенко В. М., Шамота А. З., Паронян И. Б., Константинова Н. Я., Вышинский К. В., Коновалова С. Г., Русских Н. Н., Мирошниченко М. Л. Выявление факторов риска., влияющих на потребление наркотических веществ несовершеннолетними., и разработка рекомендаций по противодействию распространению потребления наркотиков. – М., 1999.
24. Li C. Y., Mao X., Wei L. Genes and (common) pathways underlying drug addiction. PLoS Computational Biology. 2008 Jan; 4 (1): e2.
25. Doehring A., Hentig Nv., Graff J., Salamat S., Schmidt M., Geisslinger G., Harder S., Lötsch J. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution // Pharmacogenetics and Genomics. 2009 Jun; 19 (6): 407–14.
26. Lynch W. J., Taylor J. R. Persistent changes in motivation to self-administer cocaine following modulation of cyclic AMP-dependent protein kinase A (PKA) activity in the nucleus accumbens //European Journal of Neuroscience. 2005 Sep; 22 (5): 1214–20.
27. Volkow N. D., Wang G. J., Logan J., Alexoff D., Fowler J. S., Thanos P. K., Wong C., Casado V., Ferre S., Tomasi D. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain // Translational Psychiatry. 2015 Apr 14; 5: e549.
28. Savitz J. B., Ramesar R. S. Genetic variants implicated in personality: a review of the more promising candidates // American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2004Nov 15; 131B (1): 20–32.
29. Dulawa S. C., Grandy D. K., Low M. J., Paulus M. P., Geyer M. A. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli // Journal of Neuroscience. 1999 Nov 1; 19(21): 9550–6.
30. Nöthen., M. M. et al. Human dopamine D4 receptor gene: Frequent occurrence of a null allele and observation of homozygosity // Human Molecular Genetics. 1994 Dec; 3 (12): 2207–2212.
31. Clarke T. K., Weiss A. R., Ferarro T. N., Kampman K. M., Dackis C. A., Pettinati H. M., O'brien C. P., Oslin D. W., Lohoff F. W., Berrettini W. H. The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction // Annals of Human Genetics. 2014 Jan; 78 (1): 33–9.
32. Mayfield R. D., Harris R. A., Schuckit M. A. Genetic factors influencing alcohol dependence //British Journal of Pharmacology. 2008 May; 154 (2): 275–87.
33. Andreasen N. C. Creativity and mental illness: prevalence rates in writers and their first-degree relatives // American Journal of Psychiatry. 1987 Oct; 144 (10): 1288–92.
34. Luo H. R., Wu G. S., Pakstis A. J., Tong L., Oota H., Kidd K. K., Zhang Y. P. Origin and dispersal of atypical aldehyde dehydrogenase ALDH2487Lys // Gene. 2009 Apr 15;435 (1–2): 96–103.
35. Goedde H. W., Agarwal D. P., Harada S., Rothhammer F., Whittaker J. O., Lisker R. Aldehyde dehydrogenase polymorphism in North American., South American., and Mexican Indian populations //American Journal of Human Genetics. 1986 Mar; 38 (3): 395–9.
36. Li., H., et al. Refined geographic distribution of the oriental ALDH2* 504Lys (nee 487Lys) variant // Annals Of Human Genetics. 2009 May; 73 (3): 335–345.
37. Oota H. et al. The evolution and population genetics of the ALDH2 locus: random genetic drift., selection., and low levels of recombination // Annals of Human Genetics. 2004 Mar; 68 (Pt 2): 93–109.
38. Watson R. R., Preedy V. R., Zibadi S. (eds). Alcohol., Nutrition., and Health Consequences. Springer Science+Business Media. New York., 2013.
39. Dasgupta A. Alcohol and Its Biomarkers., 1st Edition. Clinical Aspects and Laboratory Determination. Elsevier 2015.
40. Bosron W. F., Li T. K. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases., and their relationship to alcohol metabolism and alcoholism // Hepatology. 1986 May-Jun; 6 (3): 502–10.
41. Kim S. G. Gender differences in the genetic risk for alcohol dependence – the results of a pharmacogenetic study in Korean alcoholics // Nihon Arukoru Yakubutsu Igakkai Zasshi (Japanese journal of alcohol studies & drug dependence). 2009. Dec; 44 (6): 680–5.
42. Higuchi S., Matsushita S., Imazeki H., Kinoshita T., Takagi S., Kono H. Aldehyde dehydrogenase genotypes in Japanese alcoholics // Lancet. 1994 Mar 19; 343 (8899): 741–2.
43. Bennion L. J., Li T. K. Alcohol metabolism in American Indians and whites. Lack of racial differences in metabolic rate and liver alcohol dehydrogenase // New England Journal of Medicine. 1976Jan 1; 294 (1): 9–13.
44. Popovici I., French M. T. Does Unemployment Lead to Greater Alcohol Consumption? //Industrial Relations. 2013 Apr; 52 (2): 444–466.
45. D'Souza D. C. et al. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia //Neuropsychopharmacology. 2006 Dec; 31 (12): 2767–75.
46. Winokur G., Coryell W., Endicott J., Keller M., Akiskal H., Solomon D. Familial alcoholism in manic-depressive (bipolar) disease // American Journal of Medical Genetics. 1996 Apr 9; 67 (2): 197–201.
47. Gorwood P., Ades J., Feingold J. Are genes coding for dopamine receptors implicated in alcoholism? // European Psychiatry. 1994; 9: 63.
48. Diaz J., Pilon C., Le Foll B., Gros C., Triller A., Schwartz J. C., Sokoloff P. Dopamine D3receptors expressed by all mesencephalic dopamine neurons // Journal of Neuroscience. 2000 Dec 1; 20(23): 8677–84.
49. Heidbreder C. A., Gardner E. L., Xi Z. X., Thanos P. K., Mugnaini M., Hagan J. J., Ashby C. R. Jr. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence //Brain Research Reviews. 2005 Jul; 49 (1): 77–105.
50. Xi Z. X., Gilbert J., Campos A. C., Kline N., Ashby C. R. Jr., Hagan J. J., Heidbreder C. A., Gardner E. L. Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats // Psychopharmacology (Berlin). 2004 Oct; 176 (1): 57–65.
51. Blum K., Noble E. P., Sheridan P. J., Montgomery A., Ritchie T., Jagadeeswaran P., Nogami H., Briggs A. H., Cohn J. B. Allelic association of human dopamine D2 receptor gene in alcoholism //Journal of the American Medical Association (JAMA). 1990 Apr 18; 263 (15): 2055–60.
52. Munafò M. R., Matheson I. J., Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias // Molecular Psychiatry. 2007 May; 12 (5): 454–61.
53. Erritzoe D. et al. In vivo imaging of cerebral dopamine D3 receptors in alcoholism //Neuropsychopharmacology. 2014 Jun; 39 (7): 1703–12.
54. Mitchell J. M., O'Neil J. P., Janabi M., Marks S. M., Jagust W. J., Fields H. L. Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens // Science Translational Medicine. 2012 Jan 11; 4 (116): 116ra6.
55. Mick I. et al. Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers // Neuropsychopharmacology. 2016 Jun; 41 (7): 1742–50.
56. Creswell K. G., Sayette M. A., Manuck S. B., Ferrell R. E., Hill S. Y., Dimoff J. D. DRD4polymorphism moderates the effect of alcohol consumption on social bonding // PLoS One. 2012; 7 (2): e28914.
57. Banerjee N. Neurotransmitters in alcoholism: A review of neurobiological and genetic studies //Indian Journal of Human Genetics. 2014 Jan-Mar; 20 (1): 20–31.
58. Wafford K. A., Whiting P. J. Ethanol potentiation of GABAA receptors requires phosphorylation of the alternatively spliced variant of the gamma 2 subunit // FEBS Letters. 1992 Nov 23; 313 (2): 113–7.
59. Zhai J., Stewart R. R., Friedberg M. W., Li C. Phosphorylation of the GABAA receptor gamma2L subunit in rat sensory neurons may not be necessary for ethanol sensitivity // Brain Research. 1998 Sep 14; 805 (1–2): 116–22.
60. Zalocusky K. A., Ramakrishnan C., Lerner T. N., Davidson T. J., Knutson B., Deisseroth K. Nucleus accumbens D2R cells signal prior outcomes and control risky decision-making // Nature. 2016Mar 31; 531 (7596): 642–6.
61. Teicher M. H., Andersen S. L., Hostetter J. C. Jr. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens // Developmental Brain Research. 1995 Nov 21; 89 (2): 167–72.
62. Seeman P., Bzowej N. H., Guan H. C., Bergeron C., Becker L. E., Reynolds G. P., Bird E. D., Riederer P., Jellinger K., Watanabe S., et al. Human brain dopamine receptors in children and aging adults // Synapse. 1987; 1 (5): 399–404.
63. Galvan A. Adolescent development of the reward system // Frontiers in Human Neuroscience. 2010 Feb 12; 4: 6.
64. Stunkard A. J., Foch T. T., Hrubec Z. A twin study of human obesity // Journal of the American Medical Association (JAMA). 1986 Jul 4; 256 (1): 51–4.
65. O'Rahilly S., Farooqi I. S. Genetics of obesity // Philosophical Transactions of the Royal Society B: Biological Sciences. 2006 Jul 29; 361 (1471): 1095–1105.
66. Hebert J. R., Patterson R. E., Gorfine M., Ebbeling C. B., St Jeor S. T., Chlebowski R. T. Differences between estimated caloric requirements and self-reported caloric intake in the women's health initiative // Annals of Epidemiology. 2003 Oct; 13 (9): 629–37.
67. Bouchard C., Tremblay A. Genetic effects in human energy expenditure components //International Journal of Obesity. 1990; 14 Suppl 1:49–55; discussion 55–8.
68. Farooqi I. S., Keogh J. M., Yeo G. S., Lank E. J., Cheetham T., O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene // New England Journal of Medicine. 2003Mar 20; 348 (12): 1085–95.
69. Appelhans B. M., Woolf K., Pagoto S. L., Schneider K. L., Whited M. C., Liebman R. Inhibiting food reward: delay discounting., food reward sensitivity., and palatable food intake in overweight and obese women // Obesity (Silver Spring). 2011 Nov; 19 (11): 2175–82.
70. Small D. M., Jones-Gotman M., Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers // NeuroImage. 2003 Aug; 19 (4): 1709–15.
71. Wang G. J., Volkow N. D., Logan J., Pappas N. R., Wong C. T., Zhu W., Netusil N., Fowler J. S. Brain dopamine and obesity // Lancet. 2001 Feb 3; 357 (9253): 354–7.
72. Duckworth A. L., Seligman M. E. Self-discipline outdoes IQ in predicting academic performance of adolescents // Psychological Science. 2005 Dec; 16 (12): 939–44.
73. Beaver K., Vaughn M., Wright J., DeLisi M. & Howard M. Three dopaminergic polymorphisms are associated with academic achievement in middle and high school // Intelligence. 2010; 38: 596–604.
74. Blum K., Noble E. Handbook of Psychiatric Genetics. CRC Press (29 Oct. 1996): 512 p., ISBN-13: 978–0849344862.
75. Barnard., N. D. et al. D2 dopamine receptor Taq1A polymorphism., body weight., and dietary intake in type 2 diabetes // Nutrition. 2009 Jan; 25 (1): 58–65.
76. Rajeevan H. et al. ALFRED – the ALlele FREquency Database. Update. // Nucleic Acids Research. 2003; 31 (1): 270–271.
77. Thomas., G. N., Critchley., J. A., Tomlinson., B., Cockram., C. S., Chan., J. C. Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects // Clinical endocrinology. 2001; 55 (5): 605–611.
78. Silveira P. P. et al. Association between the seven-repeat allele of the dopamine-4 receptor gene (DRD4) and spontaneous food intake in pre-school children // Appetite. 2014 Feb;73: 15–22.
79. Sobik L., Hutchison K., Craighead L. Cue-elicited craving for food: a fresh approach to the study of binge eating // Appetite. 2005 Jun; 44 (3): 253–61.
80. Twain M., Smith H. E. Autobiography of Mark Twain., Vol 1. University of California Press., 2012.
81. Li M. D., Cheng R., Ma J. Z., Swan G. E. A meta-analysis of estimated genetic and environmental effects on smoking behaviour in male and female adult twins // Addiction. 2003 Jan; 98(1): 23–31.
82. Huang W., Payne T. J., Ma J. Z., Li M. D. A functional polymorphism., rs6280., in DRD3 is significantly associated with nicotine dependence in European-American smokers // American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2008 Oct 5; 147B (7): 1109–15.
83. Trinidad., D. R., Pérez-Stable., E. J., Emery., S. L., White., M. M., Grana., R. A., Messer., K. S.Intermittent and light daily smoking across racial/ethnic groups in the United States // Nicotine & Tobacco Research. 2009 Feb; 11 (2): 203–210.
84. Novak G., LeBlanc M., Zai C., Shaikh S., Renou J., DeLuca V., Bulgin N., Kennedy J. L., Le Foll B. Association of polymorphisms in the BDNF., DRD1 and DRD3 genes with tobacco smoking in schizophrenia // Annals of Human Genetics. 2010 Jul; 74 (4): 291–8.
85. Khaled M. A., Farid Araki K., Li B., Coen K. M., Marinelli P. W., Varga J., Gaál J., Le Foll B. The selective dopamine D3 receptor antagonist SB 277011-A., but not the partial agonist BP 897., blocks cue-induced reinstatement of nicotine-seeking // International Journal of Neuropsychopharmacology. 2010 Mar; 13 (2): 181–90.
86. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J. C., Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization // Nature. 2001 May 3; 411 (6833): 86–9.
87. Yang J., Wang S., Yang Z., Hodgkinson C. A., Iarikova P., Ma J. Z., Payne T. J., Goldman D., Li M. D. The contribution of rare and common variants in 30 genes to risk nicotine dependence // Molecular Psychiatry. 2015 Nov; 20 (11): 1467–78.
88. Thorgeirsson T. E. et al. A variant associated with nicotine dependence., lung cancer and peripheral arterial disease // Nature. 2008 Apr 3; 452 (7187): 638–42.
89. Brunner H. G., Nelen M., Breakefield X. O., Ropers H. H., van Oost B. A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A // Science. 1993 Oct 22; 262 (5133): 578–80.
90. Raine A. From genes to brain to antisocial behaviour // Current Directions in Psychological Science. 2008; 17:323–328.
91. Lei H., Zhang X., Di X., Rao H., Ming Q., Zhang J., Guo X., Jiang Y., Gao Y., Yi J., Zhu X., Yao S. A functional polymorphism of the MAOA gene modulates spontaneous brain activity in pons //BioMed Research International. 2014; 2014: 243280.
92. Tiihonen J., Rautiainen M. R., Ollila H. M., Repo-Tiihonen E., Virkkunen M., Palotie A., Pietiläinen O., Kristiansson K., Joukamaa M., Lauerma H., Saarela J., Tyni S., Vartiainen H., Paananen J., Goldman D., Paunio T. Genetic background of extreme violent behavior // Molecular Psychiatry. 2015Jun; 20 (6): 786–92.
93. Caspi A., McClay J., Moffitt T. E., Mill J., Martin J., Craig I. W., Taylor A., Poulton R. Role of genotype in the cycle of violence in maltreated children // Science. 2002 Aug 2; 297 (5582): 851–4.
94. van der Vegt E. J., Oostra B. A., Arias-Vásquez A., van der Ende J., Verhulst F. C., Tiemeier H.High activity of monoamine oxidase A is associated with externalizing behaviour in maltreated and nonmaltreated adoptees // Psychiatric Genetics. 2009 Aug; 19 (4): 209–11.
95. Byrd A. L., Manuck S. B. MAOA., childhood maltreatment., and antisocial behavior: meta-analysis of a gene-environment interaction // Biological Psychiatry. 2014 Jan 1;75 (1): 9–17.
96. Ouellet-Morin I., Côté S. M., Vitaro F., Hébert M., Carbonneau R., Lacourse É., Turecki G., Tremblay R. E. Effects of the MAOA gene and levels of exposure to violence on antisocial outcomes //British Journal of Psychiatry. 2016 Jan; 208 (1): 42–8.
97. McDermott R., Tingley D., Cowden J., Frazzetto G., D. P. Johnson D. Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation // Proceedings of the National Academy of Sciences of the United States of America. 2009 Feb 17; 106 (7): 2118–2123.
98. Crockett M. J., Clark L., Tabibnia G., Lieberman M. D., Robbins T. W. Serotonin modulates behavioral reactions to unfairness // Science. 2008 Jun 27; 320 (5884): 1739.
99. van Donkelaar E. L., Blokland A., Ferrington L., Kelly P. A., Steinbusch H. W., Prickaerts J. Mechanism of acute tryptophan depletion: is it only serotonin? // Molecular Psychiatry. 2011 Jul; 16 (7): 695–713.
100. Bondy B., Erfurth A., de Jonge S., Krüger M., Meyer H. Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide // Molecular Psychiatry. 2000 Mar; 5 (2): 193–5.
101. Носкова Т. Г. и др. Роль гена переносчика серотонина в развитии униполярной депрессии // Материалы Международной конференции "Генетика в России и мире", посвященной 40-летию Института общей генетики им. Н. И. Вавилова РАН, Москва, 28 июня – 2 июля., 2006. М., 2006. С. 142.
102. Hariri A. R., Mattay V. S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M. F., Weinberger D. R. Serotonin transporter genetic variation and the response of the human amygdala //Science. 2002 Jul 19; 297 (5580): 400–3.
103. Kobiella A., Reimold M., Ulshöfer D. E., Ikonomidou V. N., Vollmert C., Vollstädt-Klein S., Rietschel M., Reischl G., Heinz A., Smolka M. N. How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure // Translational Psychiatry. 2011 Aug 30; 1: e37.
104. Gallinat J., Bauer M., Heinz A. Genes and neuroimaging: advances in psychiatric research //Neurodegenerative Diseases. 2008; 5 (5): 277–85.
105. Jasinska A. J., Lowry C. A., Burmeister M. Serotonin transporter gene., stress and raphe-raphe interactions: a molecular mechanism of depression // Trends in Neuroscience. 2012 Jul; 35 (7): 395–402.
106. Петровский Е. Д., Савостьянов А. Н. и др. Влияние полиморфизма аллелей серотонинового транспортера на индивидуальные особенности мозговой гемодинамики у людей в условиях экспериментальной парадигмы "стоп-сигнал" // Вавиловский журнал генетики и селекции. 2014. Т. 18. № 4/3: 1281–8.
107. Slof-Op't Landt M. C., Bartels M., Middeldorp C. M., van Beijsterveldt C. E., Slagboom P. E., Boomsma D. I., van Furth E. F., Meulenbelt I. Genetic variation at the TPH2 gene influences impulsivity in addition to eating disorders // Behavior Genetics. 2013 Jan; 43 (1): 24–33.
108. Chung I. W., Kim H., Sribney W., Hong J. B., Lee C. H., Lee K. Y., Nan H. M., Kim Y. S., Manowitz P. Tryptophan hydroxylase polymorphism is associated with age of onset of alcoholism related behaviors // Alcohol. 2005 May; 36 (1): 1–3.
109. Ruocco A. C., Rodrigo A. H., Carcone D., McMain S., Jacobs G., Kennedy J. L. Tryptophan hydroxylase 1 gene polymorphisms alter prefrontal cortex activation during response inhibition //Neuropsychology. 2016 Jan; 30 (1): 18–27.
110. Preuss N., Salehi B., van der Veen J. W., Shen J., Drevets W. C., Hodgkinson C., Goldman D., Hasler G. Associations between prefrontal γ-aminobutyric acid concentration and the tryptophan hydroxylase isoform 2 gene., a panic disorder risk allele in women // International Journal of Neuropsychopharmacology. 2013 Sep; 16 (8): 1707–17.
111. Harris A. D., Singer H. S., Horska A., Kline T., Ryan M., Edden R. A., Mahone E. M. GABA and Glutamate in Children with Primary Complex Motor Stereotypies: An 1H-MRS Study at 7T //American Journal of Neuroradiology. 2016 Mar; 37 (3): 552–7.
112. Silveri M. M., Sneider J. T., Crowley D. J., Covell M. J., Acharya D., Rosso I. M., Jensen J. E.Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition // Biological Psychiatry. 2013 Aug 15; 74 (4): 296–304.
113. Lee R., Petty F., Coccaro E. F. Cerebrospinal fluid GABA concentration: relationship with impulsivity and history of suicidal behavior., but not aggression., in human subjects // Journal of Psychiatric Research. 2009 Jan; 43 (4): 353–9.
114. Boy F., Evans C. J., Edden R. A., Lawrence A. D., Singh K. D., Husain M., Sumner P. Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity //Biological Psychiatry. 2011 Nov 1; 70 (9): 866–72.
115. Ke Yet al. Frontal lobe GABA levels in cocaine dependence: a two-dimensional., J-resolved magnetic resonance spectroscopy study // Psychiatry Research. 2004 Apr 30; 130 (3): 283–93.
116. Lane S. D., Tcheremissine O. V., Lieving L. M., Nouvion S., Cherek D. R. Acute effects of alprazolam on risky decision making in humans // Psychopharmacology (Berlin). 2005 Sep; 181 (2): 364–73.
117. Davies M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system // Journal of Psychiatry & Neuroscience. 2003 Jul; 28 (4): 263–74.
118. Kareken D. A., Liang T., Wetherill. L., Dzemidzic M., Bragulat V., Cox C., Talavage T., O'Connor S. J., Foroud T. A polymorphism in GABRA2 is associated with the medial frontal response to alcohol cues in an fMRI study // Alcoholism: Clinical and Experimental Research. 2010 Dec; 34 (12): 2169–78.
119. Hemby S. E., O'connor J. A., Acosta G., Floyd D., Anderson N., McCool B. A., Friedman D., Grant K. A. Ethanol-induced regulation of GABA-A subunit mRNAs in prefrontal fields of cynomolgus monkeys // Alcoholism: Clinical and Experimental Research. 2006 Dec; 30 (12): 1978–85.
120. Dick D. M. et al. The role of GABRA2 in risk for conduct disorder and alcohol and drug dependence across developmental stages // Behavior Genetics. 2006 Jul; 36 (4): 577–90.
121. Villafuerte S., Heitzeg M. M., Foley S., Yau W. Y., Majczenko K., Zubieta J. K., Zucker R. A., Burmeister M. Impulsiveness and insula activation during reward anticipation are associated with genetic variants in GABRA2 in a family sample enriched for alcoholism // Molecular Psychiatry. 2012 May; 17(5): 511–9.
122. Vlachou S., Markou A. GABAB receptors in reward processes // Advances in Pharmacological Sciences. 2010; 58:315–71.
123. Hayes D. J., Jupp B., Sawiak S. J., Merlo E., Caprioli D., Dalley J. W. Brain γ-aminobutyric acid: a neglected role in impulsivity // European Journal of Neuroscience. 2014 Jun; 39 (11): 1921–32.
124. Coccaro E. F., Lee R., Vezina P. Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects // Journal of Psychiatric Research. 2013 Sep; 47 (9): 1247–53.
125. Hoerst M., Weber-Fahr W., Tunc-Skarka N., Ruf M., Bohus M., Schmahl C., Ende G. Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls // Archives of General Psychiatry. 2010 Sep; 67(9): 946–54.
126. Smith H., Passik S. (eds). Pain and Chemical Dependency., 1st Edition. Oxford University Press., New York., 2008.
127. Rotberg B., Kronenberg S., Carmel M., Frisch A., Brent D., Zalsman G., Apter A., Weizman A.Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders // Journal of child and adolescent psychopharmacology. 2013 Mar; 23(2): 117–22.
